Authors: Rathke-Hartlieb, S Kahle, PJ Neumann, M Ozmen, L Haid, S Okochi, M Haass, C Schulz, JB

Citation: S. Rathke-hartlieb et al., Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice, J NEUROCHEM, 77(4), 2001, pp. 1181-1184

Authors: Eberhardt, O Coelln, RV Kugler, S Lindenau, J Rathke-Hartlieb, S Gerhardt, E Haid, S Isenmann, S Gravel, C Srinivasan, A Bahr, M Weller, M Dichgans, J Schulz, JB

Citation: O. Eberhardt et al., Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease, J NEUROSC, 20(24), 2000, pp. 9126-9134

Authors: Dehmer, T Lindenau, J Haid, S Dichgans, J Schulz, JB

Citation: T. Dehmer et al., Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo, J NEUROCHEM, 74(5), 2000, pp. 2213-2216

Authors: Soldner, F Weller, M Haid, S Beinroth, S Miller, SW Wullner, U Davis, RE Dichgans, J Klockgether, T Schulz, JB

Citation: F. Soldner et al., MPP+ inhibits proliferation of PC12 cells by a p21(WAF1/Cip1)-dependent pathway and induces cell death in cells lacking p21(WAF1/Cip1), EXP CELL RE, 250(1), 1999, pp. 75-85